Regenxbio (RGNX) Amortizatization of Intangibles (2015 - 2025)
Regenxbio (RGNX) posted quarterly Amortizatization of Intangibles of $1.2 million for Q4 2025, up 10.03% year-over-year from $1.1 million in Q4 2024, and down 32.58% quarter-over-quarter from $1.8 million in Q3 2025.
Analysis
Regenxbio (RGNX) Amortizatization of Intangibles (2015 - 2025) Analysis & Trends
Regenxbio's Amortizatization of Intangibles history runs 11 years deep, the most recent figure standing at $1.2 million for Q4 2025.
- In Q4 2025, Amortizatization of Intangibles rose 10.03% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $5.5 million (up 32.22% YoY), while the FY2025 annual figure was $5.5 million, up 32.22% from the prior year.
- Amortizatization of Intangibles for Q4 2025 stood at $1.2 million, down from $1.8 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $1.8 million in Q3 2025, with the low at -$1.6 million in Q2 2021.
- The 5-year median for Amortizatization of Intangibles is -$123500.0 (2023), against an average of -$80900.0.
- The sharpest annual moves came in 2021 and 2024: Amortizatization of Intangibles sank 3202.56% in 2021, then soared 889.47% in 2024.
- Regenxbio's Amortizatization of Intangibles stood at -$1.5 million in 2021, then surged by 38.36% to -$903000.0 in 2022, then soared by 126.8% to $242000.0 in 2023, then jumped by 361.57% to $1.1 million in 2024, then advanced by 10.03% to $1.2 million in 2025.
- Business Quant data shows RGNX's Amortizatization of Intangibles at $1.2 million in Q4 2025, $1.8 million in Q3 2025, and $1.4 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Regenxbio | 472.74 Mn | 367.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Mar 31, 2024 | 468,000.00 |
| Dec 31, 2023 | 242,000.00 |
| Sep 30, 2023 | 133,000.00 |
| Jun 30, 2023 | -380,000.00 |
| Mar 31, 2023 | -682,000.00 |
| Dec 31, 2022 | -903,000.00 |
| Sep 30, 2022 | -1.13 Mn |
| Jun 30, 2022 | -1.22 Mn |
| Mar 31, 2022 | -1.46 Mn |
| Dec 31, 2021 | -1.47 Mn |
| Sep 30, 2021 | -1.51 Mn |
| Jun 30, 2021 | -1.58 Mn |
| Mar 31, 2021 | -1.29 Mn |